Table 1 Patient clinical, imaging and pathological details
Patient | PSA level (ng/mL) | Pathological T-stage | Prostate volume (cm3) | # Histology slices | GG (index lesion) | GG (other foci) | PIRADS v2 (index lesion) | SUVmax |
|---|---|---|---|---|---|---|---|---|
11 | 6.8 | T3b | 36.89 | 4 | 3 | 3, 4 | 5 | 3.88 |
12 | 16 | T3a | 64.35 | 4 | 3 | – | 5 | 6.47 |
20 | 9 | T3b | 33.25 | 5 | 5 | 1, 2, 4 | 4 | 9.64 |
26 | 42 | T3a | 52.17 | 4 | 3 | 1 | 4 | 12.11 |
34 | 8.1 | T3a | 50.34 | 4 | 2 | 2 | 5 | 3.70 |
46 | 3.2 | pT2 | 33.49 | 3 | 3 | 1, 2 | 4 | 3.08 |
51 | 18 | pT2 | 54.08 | 6 | 2 | 1 | 5 | 5.04 |
53 | 10 | pT3a | 33.77 | 5 | 3 | – | 5 | 5.95 |
54 | 12 | pT2 | 34.03 | 5 | 2 | 1 | 3 | 6.45 |
55 | 6.5 | pT2 | 30.23 | 4 | 3 | 1, 2 | 5 | 14.78 |
56 | 6.6 | pT2 | 41.07 | 5 | 2 | 2 | 5 | 2.43 |
58 | 5.6 | pT3b | 48.55 | 5 | 5 | Mix of 1–5 | 5 | 15.76 |
59 | 10.7 | pT3a | 39.40 | 5 | 2 | – | Indeterminate | 10.91 |
60 | 6.7 | pT3a | 49.80 | 5 | 2 | 1 | 4 | 3.23 |
62 | 10.7 | pT3a | 31.81 | 4 | 5 | 1 | 5 | 46.34 |
64 | 9 | pT3a | 37.44 | 5 | 3 | 1, 2 | 5 | 59.40 |
65 | 7.3 | pT2 | 35.69 | 4 | 2 | 1, 2 | 5 | 7.79 |
66 | 6.5 | pT2 | 26.21 | 5 | 2 | – | 2 | 8.46 |
68 | 10.8 | pT2 | 57.33 | 8 | 2 | 1, 2 | 5 | 5.75 |